Greana Kirubakar, Dr. rer. nat

InfectionBiologist looking for research opportunities @ USA #researched MTB&NTM#worked @Cornell@RobertKochInstitut#ICMR-NIRT#You-Tuber#Singer#motivtional writer

[Greana Kirubakar, Dr. rer. nat @GreanaK]

🫁 I’m excited to serve as Topic Coordinator for this Frontiers Research Topic on The Pulmonary Microbiome in Tuberculosis.
I invite researchers in TB, microbiome research, host–microbe interactions, diagnostics, and therapeutics to submit their work -@FrontiersIn #Microbiome#TB

[Science Magazine @ScienceMagazine]

Chemically enhanced suppressor tRNAs combined with a lung-targeted delivery system can restore production of a critical protein in models of cystic fibrosis caused by nonsense mutations, according to a new study in Science.

📄: https://t.co/XFDfZTFImB
#SciencePerspective: https://t.co/oa2gepbJU3

[Greana Kirubakar, Dr. rer. nat @GreanaK]

I had the opportunity to give a seminar talk in India, on the topic “The Adventure of Discovery – Choosing Research as a Career Path.”  During the talk, I shared my experiences and encouraged students to take that first step of faith toward research, even with limited resources

[Science Magazine @ScienceMagazine]

A new @SciImmunology study shows that mycobacterium tuberculosis can survive within macrophages by binding dectin1 and altering phagosome maturation and autophagy. https://t.co/sYPSHRPwPM

[Greana Kirubakar, Dr. rer. nat @GreanaK]

https://t.co/w8WZSQ5mMM
I’m thrilled to share that my latest research article has been published in the Antimicrobial Agents and Chemotherapy (AAC) journal and has been selected as an Editor’s Pick!
A big thank you to my collaborators, mentors, and colleagues 🙏

[Biohack Yourself Magazine @biohackyourself]

AI Cracks the Code of How TB Drugs Kill

Tuberculosis (TB) remains the world’s deadliest infectious disease, demanding long treatments and facing rising drug resistance. Now, Tufts University researchers have developed an AI tool that shows exactly how TB drugs kill bacteria—unlocking faster paths to better cures.

The new platform, called DECIPHAER, combines high-resolution images of dying TB bacteria with molecular readouts of bacterial gene activity. This approach allowed scientists to map, in detail, the precise “mechanism of death” for different drugs. In one case, the tool revealed that a TB drug in development, previously thought to destroy the bacterial cell wall, actually kills by shutting down the cell’s respiratory chain and energy production.

By predicting a drug’s molecular impact from simple images, this method is cheaper, faster, and capable of guiding smarter drug combinations. While designed for TB, the technique could also be applied to other infectious diseases and cancer.

📖 Source: Tufts University via Cell Systems (July 29, 2025)
https://t.co/OjnmKXoDqT

👉 Comment BIOHACK if you want more science and health news like this!

#BiohackYourself #TBResearch #Microbiology #ArtificialIntelligence #DrugResistance #HealthTech #AIHealth #InfectiousDiseases #ModernMedicine #PrecisionMedicine

Disclaimer:
This content is for educational and entertainment purposes only and is not a substitute for medical advice. Always consult a healthcare professional. Full disclaimer: https://t.co/UEyZoUqm2Y

🧠 We explore all angles — ancient wisdom, modern science, and everything in between. No allegiance to Big Pharma or Big Natural.
🔍 We cite studies, but encourage you to read them, question funding, and review the methods. Stay curious.
📚 Not all journals are equal. Peer-reviewed ≠ perfect. Check the source, think critically, and decide for yourself.
⚠️ One study isn’t the full story. Science evolves. We’re here to inform, not to tell you what to believe.

[Greana Kirubakar, Dr. rer. nat @GreanaK]

I had an opportunity to address and mentor young Bio-medical engineers in my home country. It was a privilege to share my career journey, few tips to boost their career development and answer their curiosity about starting a research career.

[Science Magazine @ScienceMagazine]

"Research is messy. … Trying to protect students from that reality does them a disservice."

On #InternationalDayOfEducation, take a look back at this #ScienceWorkingLife on teaching students about scientific failure. https://t.co/LG0prXpxYf

[Rosalind Franklin Institute @RosFrankInst]

The team, from the Franklin, @OxfordMedSci and @NIH in the USA, have developed a more accurate way to scan for tuberculosis in work published in @NatureComms today. Read more about this here - https://t.co/PuCX2pFque

[Gates Medical Research Institute @GatesMRI]

The M72/AS01E vaccine candidate, if proven well tolerated and effective, could have the potential to make strides in preventing latent TB from becoming pulmonary TB in adolescents and adults.

Read more about the clinical trial here: https://t.co/glKfIa7rjX

[Dr. Catharine Young @DrCatharineY]

How can this be so true and hurt so much at the same time 😂😭

[Mindset Machine @mindsetmachine]

No discipline = no success

Ignoring health = neglecting wealth

Avoiding challenges = fearing growth

Lack of ambition = acceptance of mediocrity

Preferring comfort = missing opportunities.

[Science Careers @ScienceCareers]

When you're the only woman: The challenges for female Ph.D. students in male-dominated cohorts

Without peers of the same gender, female Ph.D. students are less likely to graduate, according to a new study. #WomenHistoryMonth #WomenInSTEM #PhDChat https://t.co/HfREsedW6C

[Dr. Catharine Young @DrCatharineY]

Don’t live in your past. Always look forward.
Credit: @lizandmollie

[Carlos Martin @CarlosMTBVAC]

Clinical trials of Spanish tuberculosis vaccine MTBVAC begin in India - The Hindu https://t.co/rkxFbHTPYM

[Albert Einstein College of Medicine - Official @EinsteinMed]

For #WomensHistoryMonth, Einstein celebrates Salome Gluecksohn Waelsch, Ph.D., who pioneered developmental genetics by applying genetic theory and practice to embryology. #WHM #IWD2024

[Nature Reviews Microbiology @NatureRevMicro]

Drug-resistant tuberculosis: a persistent global health concern

https://t.co/PQCWhHB3fy

Ahead of #WorldTBDay this weekend, Pai (@paimadhu) & co review the global landscape of drug-resistant TB, its causes, risk factors, impact, latest diagnostics, treatments, and more.